Well-defined poly(2-hydroxyl-3-(2-hydroxyethylamino)propyl methacrylate) vectors with low toxicity and high gene transfection efficiency

Biomacromolecules

Volumn 11, Issue 6, 2010, Pages 1437-1442

  Xu, F J ^a   Chai, M Y ^a   Li, W B ^b   Ping, Y ^a   Tang, G P ^c   Yang, W T ^a   Ma, J ^b   Liu, F S ^d  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC MONOMERS; CELL CULTURE; GENE TRANSFER; NUCLEIC ACIDS; POLYMER BLENDS; TOXICITY; VECTORS;

AMINE MOIETIES; CELL LINES; CLINICAL TRANSLATION; CYTOTOXICITY ASSAYS; EPOXIDE GROUPS; ETHANOLAMINES; GENE DELIVERY VECTORS; GENE TRANSFECTION; HYDROXYL UNITS; LOW TOXICITY; NONIONIC; POLY(GLYCIDYL METHACRYLATE); POLYETHYLENIMINES; PROPYL METHACRYLATE; RING OPENING REACTION; SECONDARY AMINES; TRANSFECTION EFFICIENCY;

GENE THERAPY;

AMINE; CATION; DRUG CARRIER; EPOXIDE; ETHANOLAMINE; HYDROXYL GROUP; PLASMID DNA; POLY [2 HYDROXYL 3 (2 HYDROXYETHYLAMINO)PROYLMETHACRYLATE]; POLYETHYLENEIMINE; UNCLASSIFIED DRUG; DNA; LUCIFERASE; POLY(2-HYDROXYL-3-(2-HYDROXYETHYLAMINO)PROPYL METHACRYLATE); POLYMETHACRYLIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL STRAIN HEK293; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; GENE DELIVERY SYSTEM; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; RING OPENING; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECTS; GENE TRANSFER; GENETICS; MOLECULAR CLONING; PLASMID; RENILLA; SYNTHESIS; TOXICITY;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; CLONING, MOLECULAR; DNA; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HUMANS; LUCIFERASES; MOLECULAR STRUCTURE; PLASMIDS; POLYMETHACRYLIC ACIDS; RENILLA; TRANSFECTION;

EID: 77954612736     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm100309y     Document Type: Article

References (19)

1. Marshall, E. Science 1999, 286, 2244-2245.
2. Hunt, K. K.; Vorburger, S. A. Science 2002, 297, 415-416.
3. Niidome, T.; Huang, L. Gene Ther. 2002, 9, 1647-1652.
4. Bisht, H. S.; Manickam, D. S.; You, Y.; Oupicky, D. Biomacromolecules 2006, 7, 1169-1178.
5. Xu, F. J.; Li, H. Z.; Li, J.; Zhang, Z. X.; Kang, E. T.; Neoh, K. G. Biomaterials 2008, 29, 3023-3033.
6. De Smedt, S. C.; Demeester, J.; Hennink, W. E. Pharm. Res. 2000, 17, 113-126.
7. Wagner, E.; Ogris, M.; Zauner, W. Adv. Drug Delivery Rev. 1998, 30, 97-113.
8. Kukowska-Latallo, J. F.; Bielinska, A. U.; Johnson, J.; Spindler, R.; Tomalia, D. A.; Baker, J. R., Jr. Proc. Natl. Acad. Sci. USA 1996, 93, 4897-4902.
9. Breunig, M.; Lungwitz, U.; Liebl, R.; Goepferich, A. Proc. Natl. Acad. Sci. USA 2007, 104, 14454-14459.
10. Neu, M.; Fischer, D.; Kissel, T. J. Gene Med. 2005, 7, 992-1009.
11. Yang, C.; Li, H.; Goh, S. H.; Li, J. Biomaterials 2007, 28, 3245-3254.
12. Xu, F. J.; Ping, Y.; Ma, J.; Tang, G. P.; Yang, W. T.; Kang, E. T.; Neoh, K. G. Bioconjugate Chem. 2009, 20, 1449-1458.
13. Blessing, T.; Kursa, M.; Holzhauser, R.; Kircheis, R.; Wagner, E. Bioconjugate Chem 2001, 12, 529-537.
14. Han, M.; Bae, Y.; Nishiyama, N.; Miyata, K.; Oba, M.; Kataoka, K. J. Controlled Release 2007, 121, 38-48.
15. Wang, D. A.; Narang, A. S.; Kotb, M.; Gaber, A. O.; Miller, D. D.; Kim, S. W.; Mahato, R. I. Biomacromolecules 2002, 3, 1197-1207.
16. Zhang, X. Q.; Wang, X. L.; Huang, S. W.; Zhou, R. X.; Liu, Z. L.; Mao, H. Q.; Leong, K. W. Biomacromolecules 2005, 6, 341-350.
17. Wetering, P. V. D.; Moret, E. E.; Nieuwenbroek, N. M. E.; Steenbergen, M. J. V.; Hennink, W. E. Bioconjugate Chem. 1999, 10, 589-597.
18. Boussif, O.; Lezoualc'h, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. Proc. Natl. Acad. Sci. USA 1995, 92, 7297-7301.
19. Masago, K.; Itaka, K.; Nishiyama, N.; Chung, U.; Kataoka, K. Biomaterials 2007, 28, 5169-5175.